Get started
Author

Maria Chini

Observed names: Chini, M., Chini, Maria, M CHINI, M Chini, M. Chini, Maria C Chini
Observed institutions: University of Ioannina, National and Kapodistrian University of Athens, Hellenic Red Cross, Red Cross Hospital, General Hospital of Athens G. Genimatas, General Hospital of Athens Elpis, Evangelismos Hospital
ORCID: 0000-0002-4551-3024
Observed ORCID: 0000-0002-4551-3024
OpenAlex ID: A5060683970
Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial
2021 · Evdoxia Kyriazopoulou, Garyfallia Poulakou, et al. · Nature Medicine · 562
PDF
The Role of Platelet-Activating Factor in Chronic Inflammation, Immune Activation, and Comorbidities Associated with HIV Infection.
2015 · Theodoros Kelesidis, Vasiliki Papakonstantinou, et al. · PubMed · 62
Prevalence of resistance-associated mutations in newly diagnosed HIV-1 patients in Greece
2005 · D. Paraskevis, E. Magiorkinis, et al. · Virus Research · 46
Cardiovascular risk factors in HIV infected individuals: Comparison with general adult control population in Greece
2020 · Giota Touloumi, Natasa Kalpourtzi, et al. · PLoS ONE · 44
PDF
Anti-Platelet-Activating Factor Effects of Highly Active Antiretroviral Therapy (HAART): A New Insight in the Drug Therapy of HIV Infection?
2008 · Alexandros B. Tsoupras, Maria Chini, et al. · AIDS Research and Human Retroviruses · 43
Factors Associated with Healthcare Workers’ (HCWs) Acceptance of COVID-19 Vaccinations and Indications of a Role Model towards Population Vaccinations from a Cross-Sectional Survey in Greece, May 2021
2021 · Konstantinos Fotiadis, Katerina Dadouli, et al. · International Journal of Environmental Research and Public Health · 39
PDF
Development and validation of SCOPE score: A clinical score to predict COVID-19 pneumonia progression to severe respiratory failure
2022 · Evangelos J. Giamarellos-Bourboulis, Garyfallia Poulakou, et al. · Cell Reports Medicine · 34
PDF
Author Correction: Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial
2021 · Evdoxia Kyriazopoulou, Garyfallia Poulakou, et al. · Nature Medicine · 34
PDF
Platelet-Activating Factor and Its Basic Metabolic Enzymes in Blood of Naive HIV-Infected Patients
2011 · Alexandros B. Tsoupras, Maria Chini, et al. · Angiology · 34
Long-term evolution of CD4+ cell count in patients under combined antiretroviral therapy
2019 · Nikos Pantazis, Vasilios Papastamopoulos, et al. · AIDS · 33
Prevalence of drug resistance among HIV-1 treatment-naive patients in Greece during 2003–2015: Transmitted drug resistance is due to onward transmissions
2017 · D. Paraskevis, E. Kostaki, et al. · Infection Genetics and Evolution · 33
Immunogenicity and Immunological Memory Induced by the 13-Valent Pneumococcal Conjugate Followed by the 23-Valent Polysaccharide Vaccine in HIV-Infected Adults
2018 · Paraskevi F Farmaki, Maria C Chini, et al. · The Journal of Infectious Diseases · 26
PDF
In vivo effect of two first-line ART regimens on inflammatory mediators in male HIV patients
2014 · Vasiliki D Papakonstantinou, Maria Chini, et al. · Lipids in Health and Disease · 26
PDF
Efficacy and safety of early soluble urokinase plasminogen receptor plasma-guided anakinra treatment of COVID-19 pneumonia: a subgroup analysis of the SAVE-MORE randomised trial
2022 · Karolina Akinosoglou, Antigone Kotsaki, et al. · EClinicalMedicine · 25
PDF
In vitro anti-inflammatory and anti-coagulant effects of antibiotics towards Platelet Activating Factor and thrombin
2011 · Alexandros B Tsoupras, Maria Chini, et al. · Journal of Inflammation · 22
PDF
Transitions of blood immune endotypes and improved outcome by anakinra in COVID-19 pneumonia: an analysis of the SAVE-MORE randomized controlled trial
2024 · Evdoxia Kyriazopoulou, Yehudit Hasin-Brumshtein, et al. · Critical Care · 21
PDF
Analytical and clinical sensitivity of the Procleix Ultrio HIV‐1/HCV/HBV assay in samples with a low viral load
2006 · A. Katsoulidou, Z. Moschidis, et al. · Vox Sanguinis · 20
Mutations associated with genotypic resistance to antiretroviral therapy in treatment naı̈ve HIV-1 infected patients in Greece
2002 · E. Magiorkinis, D. Paraskevis, et al. · Virus Research · 20
Low pre-ART CD4 count is associated with increased risk of clinical progression or death even after reaching 500 CD4 cells/μL on ART
2023 · Nikos Pantazis, Vasilios Paparizos, et al. · PLoS ONE · 19
PDF
Interferon gamma-induced protein 10 (IP-10) for the early prognosis of the risk for severe respiratory failure and death in COVID-19 pneumonia
2022 · Charilaos Samaras, Evdoxia Kyriazopoulou, et al. · Cytokine · 19
Changes in Body Mass Index after Initiation of Antiretroviral Treatment: Differences by Class of Core Drug
2022 · Nikos Pantazis, Vasilios Papastamopoulos, et al. · Viruses · 19
PDF
HIV cascade of care in Greece: Useful insights from additional stages
2018 · Georgia Vourli, Georgios Nikolopoulos, et al. · PLoS ONE · 18
PDF
Platelet count kinetics following interruption of antiretroviral treatment
2012 · Eva Zetterberg, Jacqueline Neuhaus, et al. · AIDS · 18
Estimation of the determinants for HIV late presentation using the traditional definition and molecular clock‐inferred dates: Evidence that older age, heterosexual risk group and more recent diagnosis are prognostic factors
2022 · Evangelia Georgia Kostaki, Stefanos Limnaios, et al. · HIV Medicine · 17
PDF
Vaccination coverage rates and attitudes towards mandatory vaccinations among healthcare personnel in tertiary-care hospitals in Greece
2022 · Helena C. Maltezou, Maria Tseroni, et al. · Expert Review of Vaccines · 17
Works count: 82
Citation count: 1,496
H-index: 19
I10-index: 36
Year
Topic
Type